蔚蓝生物
(603739)
| 流通市值：32.51亿 | | | 总市值：32.51亿 |
| 流通股本：2.53亿 | | | 总股本：2.53亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 230,281,328.08 | 230,012,716.89 | 244,157,573.25 | 215,679,228.18 |
| 交易性金融资产 | 241,828,877.94 | 267,372,201.37 | 224,866,908.03 | 223,095,833.41 |
| 应收票据及应收账款 | 437,075,767.15 | 401,769,277.03 | 405,548,467.29 | 420,671,617.34 |
| 其中：应收票据 | 26,693,281.88 | 14,549,327.98 | 26,533,287.1 | 12,601,553.03 |
| 应收账款 | 410,382,485.27 | 387,219,949.05 | 379,015,180.19 | 408,070,064.31 |
| 应收款项融资 | 9,415,188.43 | 4,624,088.53 | 3,722,769.03 | 4,090,838.44 |
| 预付款项 | 25,165,828.54 | 43,748,059.83 | 10,700,133.69 | 24,493,513.92 |
| 其他应收款合计 | 38,534,265.11 | 45,842,110.42 | 41,970,018.07 | 40,168,264.51 |
| 存货 | 242,861,156.3 | 230,518,458.27 | 226,369,014.44 | 216,743,499.06 |
| 一年内到期的非流动资产 | 6,000,000 | 7,000,000 | 9,000,000 | - |
| 其他流动资产 | 7,334,630.76 | 7,097,301.77 | 12,284,299.25 | 4,344,485.39 |
| 流动资产合计 | 1,238,497,042.31 | 1,237,984,214.11 | 1,178,619,183.05 | 1,149,287,280.25 |
| 非流动资产: | | | | |
| 债权投资 | 5,000,000 | 5,000,000 | 5,000,000 | 14,000,000 |
| 长期股权投资 | 4,438,223.8 | 63,853,720.93 | 63,934,462.23 | 74,588,849.7 |
| 其他权益工具投资 | 5,904,929.82 | 5,904,929.82 | 7,315,229.82 | 5,996,056.64 |
| 固定资产 | 1,442,836,147.16 | 1,460,620,932.4 | 1,486,115,581.93 | 1,305,439,872.53 |
| 在建工程 | 30,539,281.54 | 31,319,741.69 | 37,395,397.76 | 216,297,114.23 |
| 无形资产 | 137,875,193.17 | 129,287,228.74 | 126,722,253.28 | 127,322,169.05 |
| 商誉 | 84,202,475.98 | 84,202,475.98 | 84,202,475.98 | 84,202,475.98 |
| 长期待摊费用 | 1,213,391.55 | 1,465,299.68 | 1,264,043.17 | 1,601,111.63 |
| 递延所得税资产 | 24,126,935.27 | 24,486,076.7 | 23,554,298.22 | 22,485,648.3 |
| 其他非流动资产 | 41,283,654.3 | 32,011,388.98 | 25,536,373.88 | 40,311,096.6 |
| 非流动资产合计 | 1,777,420,232.59 | 1,838,151,794.92 | 1,861,040,116.27 | 1,892,244,394.66 |
| 资产总计 | 3,015,917,274.9 | 3,076,136,009.03 | 3,039,659,299.32 | 3,041,531,674.91 |
| 流动负债: | | | | |
| 短期借款 | 602,990,240.07 | 620,433,138.62 | 582,874,900.68 | 608,520,498.24 |
| 应付票据及应付账款 | 207,009,055.58 | 215,803,502.19 | 194,413,507.31 | 204,134,141.47 |
| 其中：应付票据 | 3,850,000 | 3,850,000 | 1,480,000 | 2,563,600 |
| 应付账款 | 203,159,055.58 | 211,953,502.19 | 192,933,507.31 | 201,570,541.47 |
| 合同负债 | 19,036,992.92 | 22,721,547.39 | 14,247,030.44 | 16,292,675.77 |
| 应付职工薪酬 | 27,089,059.2 | 19,270,090.3 | 36,266,569.56 | 32,986,478.66 |
| 应交税费 | 16,958,499.06 | 17,443,856.29 | 17,543,138.74 | 18,581,548.98 |
| 其他应付款合计 | 107,501,338.26 | 118,865,200.17 | 110,751,834.17 | 113,819,047.66 |
| 应付股利 | 490,000 | - | - | - |
| 一年内到期的非流动负债 | 15,937,637.71 | 26,020,325.15 | 36,117,905.05 | 62,320,325.15 |
| 其他流动负债 | 5,457,004.18 | - | 14,869,986.46 | 6,691,116.21 |
| 流动负债平衡项目 | 0 | -0.01 | 0 | 0 |
| 流动负债合计 | 1,001,979,826.98 | 1,040,557,660.1 | 1,007,084,872.41 | 1,063,345,832.14 |
| 非流动负债: | | | | |
| 长期借款 | 49,905,111.11 | 50,057,715.34 | 59,787,180.56 | 13,806,437.56 |
| 预计负债 | 1,109,869.6 | 1,109,869.6 | 1,109,869.6 | - |
| 递延收益 | 52,894,018.57 | 56,089,976.79 | 59,579,262.09 | 60,841,342.45 |
| 递延所得税负债 | 1,339,361.65 | 2,208,707.57 | 1,378,499.64 | 2,335,958.81 |
| 非流动负债合计 | 105,248,360.93 | 109,466,269.3 | 121,854,811.89 | 76,983,738.82 |
| 负债平衡项目 | 0 | 0.01 | 0 | 0 |
| 负债合计 | 1,107,228,187.91 | 1,150,023,929.41 | 1,128,939,684.3 | 1,140,329,570.96 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 253,028,866 | 253,028,866 | 253,028,866 | 253,028,866 |
| 资本公积 | 702,898,795.16 | 702,898,795.16 | 702,898,795.16 | 702,898,795.16 |
| 其他综合收益 | -14,804,093.55 | -15,167,353.92 | -14,810,179.38 | -15,273,966.11 |
| 盈余公积 | 60,751,469.52 | 60,751,469.52 | 60,751,469.52 | 56,085,169.04 |
| 未分配利润 | 793,909,252.11 | 798,241,209.87 | 780,652,368.19 | 777,288,145.15 |
| 归属于母公司股东权益合计 | 1,795,784,289.24 | 1,799,752,986.63 | 1,782,521,319.49 | 1,774,027,009.24 |
| 少数股东权益 | 112,904,797.75 | 126,359,092.99 | 128,198,295.53 | 127,175,094.71 |
| 股东权益合计 | 1,908,689,086.99 | 1,926,112,079.62 | 1,910,719,615.02 | 1,901,202,103.95 |
| 负债和股东权益合计 | 3,015,917,274.9 | 3,076,136,009.03 | 3,039,659,299.32 | 3,041,531,674.91 |
| 公告日期 | 2026-08-28 | 2026-04-25 | 2026-04-25 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |